Modular Medical (OTC:MODD – Get Rating) and Haemonetics (NYSE:HAE – Get Rating) are both medical companies, but which is the superior stock? We will contrast the two companies based on the strength of their risk, earnings, institutional ownership, profitability, dividends, analyst recommendations and valuation.
This table compares Modular Medical and Haemonetics’ net margins, return on equity and return on assets.
|Net Margins||Return on Equity||Return on Assets|
This is a summary of recent ratings and target prices for Modular Medical and Haemonetics, as provided by MarketBeat.
|Sell Ratings||Hold Ratings||Buy Ratings||Strong Buy Ratings||Rating Score|
Earnings & Valuation
This table compares Modular Medical and Haemonetics’ gross revenue, earnings per share and valuation.
|Gross Revenue||Price/Sales Ratio||Net Income||Earnings Per Share||Price/Earnings Ratio|
|Modular Medical||N/A||N/A||-$18.63 million||($1.48)||-0.72|
|Haemonetics||$1.17 billion||3.58||$115.40 million||$2.23||37.17|
Haemonetics has higher revenue and earnings than Modular Medical. Modular Medical is trading at a lower price-to-earnings ratio than Haemonetics, indicating that it is currently the more affordable of the two stocks.
Risk & Volatility
Modular Medical has a beta of 0.21, indicating that its share price is 79% less volatile than the S&P 500. Comparatively, Haemonetics has a beta of 0.44, indicating that its share price is 56% less volatile than the S&P 500.
Institutional and Insider Ownership
14.7% of Modular Medical shares are held by institutional investors. 59.2% of Modular Medical shares are held by insiders. Comparatively, 1.7% of Haemonetics shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth.
Haemonetics beats Modular Medical on 9 of the 13 factors compared between the two stocks.
About Modular Medical
Modular Medical, Inc., a development stage medical device company, focuses on the design, development, and commercialization of insulin pumps using technology to enhance pump adoption in the diabetes marketplace. The company is headquartered in San Diego, California.
Haemonetics Corp. is a global healthcare company, which engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, Hospital, and Corporate. The Plasma segment offers automated plasma collection and donor management software systems. The Blood Center segment provides solutions for donor collection centers’ ability to acquire blood, filter blood, and separate blood components. The Hospital segment includes hemostasis management, cell salvage, and transfusion management services that help decision makers in hospitals optimize blood acquisition, storage, and usage in critical settings. The company was founded by Allen Latham, Jr. in 1971 and is headquartered in Boston, MA.
Receive News & Ratings for Modular Medical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Modular Medical and related companies with MarketBeat.com's FREE daily email newsletter.